Summit Therapeutics (SMMT-Q)
NASDAQ:SMMT
19.75
0.31
(1.59%) 1d
Financials
Technical Analysis
Buy, Sell or Hold?
This summary was created by AI, based on 1 opinions in the last 12 months.
Summit Therapeutics (SMMT-Q) is currently viewed with skepticism by analysts, primarily due to its lack of profitability and designation as a speculative investment. The company's financial status raises red flags, suggesting a high level of risk for potential investors. This type of speculative stock often attracts those looking for high-reward opportunities, but it simultaneously comes with the potential for significant losses. The general sentiment indicates that investors should approach SMMT-Q with caution, considering its current financial metrics and the wider market context. As the company navigates its path forward, the need for clarity on its business model and financial viability remains paramount for fostering investor confidence.
- «
- ‹
- 1
- ›
- »
Summit Therapeutics(SMMT-Q) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 1
Total Signals / Votes : 1
Summit Therapeutics(SMMT-Q) Frequently Asked Questions
What is Summit Therapeutics stock symbol?
Summit Therapeutics is a American stock, trading under the symbol SMMT-Q on the NASDAQ (SMMT). It is usually referred to as NASDAQ:SMMT or SMMT-Q
Is Summit Therapeutics a buy or a sell?
In the last year, 1 stock analyst published opinions about SMMT-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Summit Therapeutics.
Is Summit Therapeutics a good investment or a top pick?
Summit Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Summit Therapeutics.
Why is Summit Therapeutics stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Summit Therapeutics worth watching?
In the last year 1 stock analyst on Stockchase covered Summit Therapeutics. The stock is worth watching.
What is Summit Therapeutics stock price?
On 2025-03-21, Summit Therapeutics (SMMT-Q) stock closed at a price of $19.75.
Doesn't make money and is a risky spec.